StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note issued to investors on Monday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 7.3 % Brooklyn ImmunoTherapeutics stock opened at $1.01 on Monday. The firm has a market cap of $59.41 million, a […]